2. INTRODUCTION
India is today recognized as one of
the leading global players in
pharmaceuticals.
Indiian pharma industry has shown
tremendous progress in terms of
infrastructure
development, technology base &
wide range of products.
3. Contd….
The industry now produces bulk drugs
belonging to all major therapeutic
groups requiring complicated
manufacturing processes and has also
developed excellent GMP (Good
Manufacturing Practices) compliant
facilities for the production of different
dosage forms.
The strength of the industry is in
developing cost effective technologies
in the shortest possible time for drug
intermediates and bulk activities
without compromising on quality.
4. THE DOMESTIC PHARMA
INDUSTRY pharma industry has
Domestic
recently achieved some historic
milestones through a leadership
position and global presence as a
world class cost effective generic
drugs' manufacturer of AIDS
medicines.
Many Indian companies maintain
highest standards in Purity, Stability
and International Safety, Health and
Environmental (SHE) protection in
production and supply of bulk drugs
even to some innovator companies.
5. Contd…
Many Indian companies are part of
an agreement where major AIDS
drugs based on Lamivudine,
Stavudine, Zidovudine, Nevirapine
will be supplied to Mozambique,
Rwanda, South Africa and Tanzania
which have about 33% of all people
living with AIDS in Africa. Yet
another US Scheme envisages
sourcing Anti Retrovirals from some
Indian companies whose products
are already US FDA approved.
6. Contd…
Increasing number of Indian
pharmaceutical companies have been
getting international regulatory approvals
for their plants from agencies like
USFDA (USA), MHRA (UK), TGA
(Australia), MCC (South Africa), Health
Canada etc.
Indian companies are now seeking more
Abbreviated New Drug Approvals
(ANDAs) in USA in specialized segments
like anti-infective, cardio vascular and
central nervous system groups.
7. FACTS &
FIGURES
The annual turnover of Indian
pharmaceuticals industry in 2006-07
was approx $17 billion (over 68,000
crore).
The share of export of
drugs, pharmaceuticals, & fine
chemicals was more than 24,000
cr.(around us $ 6 billion) .
8. Contd…
Europe accounts for the highest share of
over 23% of Indian Pharma exports
followed by North America and Asia.
Exports to USA have crossed the land
mark figure of US $1 billion during 2006-
07.
It is estimated that by the year 2010, the
Indian pharmaceutical industry has the
potential to achieve over Rs.1,00,000
crore production of formulations and bulk
drugs.
9. PRODUCTION
During 2007-08 several proposals for
technology transfer including joint
ventures, proposals for foreign direct
investment, setting up of new
undertakings/expansion of existing units
(manufacture of new articles in the
existing units) have been received and
processed. Following the de-licensing of
the pharmaceutical industry, industry is
now required to submit Industrial
Entrepreneurial Memorandums (lEMs) for
the manufacture of various bulk
drugs/drug intermediates /formulations.
10. EXPORTS
Year Exports(Rs. In Growth(%)
crore)
2003-04 15213 18.61
2004-05 17857 17.38
2005-06 22216 24.41
2006-07 24942 12.27
Source: Directorate General of Commercial Intelligence and Statistics
(DGCIS) Kolkata
11. INDUSTRY
STRENGTHS
Knowledge based Industry
Large manufacturing base for high
quality drugs and formulations
Developing cost effective
technologies for drug
intermediaries and bulk actives
without a compromise on quality
12. Contd…..
Cost advantage in terms of drug
production, maintenance of high
standards in terms of purity, stability and
international safety, health and
environment protection
Tremendous export potential
Major driver of growth in the future
Strong scientific and technical
manpower
13. Contd….
World class national laboratories in
process development
Increasing balance of trade in the sector
An excellent centre for clinical trials
Competencies in chemistry and process
development
